Bregua Corp 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-04 4:05 pm Sale | 2024-09-30 | 13G | Janux Therapeutics, Inc. JANX | Bregua Corp | 2,999,990 5.800% | -830,267 (-21.68%) | Filing |
| 2024-02-01 4:15 pm Purchase | 2023-12-31 | 13G | Janux Therapeutics, Inc. JANX | Bregua Corp | 3,830,257 8.300% | 81,007 (+2.16%) | Filing |
| 2021-06-25 06:08 am Purchase | 2021-06-15 | 13G | Janux Therapeutics, Inc. JANX | Bregua Corp | 3,749,250 9.000% | 3,749,250 (New Position) | Filing |